Trials / Unknown
UnknownNCT02471625
Traumatic Brain Injury Feasibility Study (EPIC-011)
Traumatic Brain Injury (TBI) Feasibility Study to Determine Possible Prognostic Indicators as Provided by the EPIC ClearView™
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Epic Research & Diagnostics, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research study is to evaluate whether data made by the ClearView System can be used to detect whether someone has a traumatic brain injury and how severe the injury is.
Detailed description
Traumatic brain injury (TBI) is a significant cause of death and disability in the U.S. The severity of a TBI may range from "mild" (i.e. a brief change in mental status or consciousness) to "severe" (i.e. an extended period of unconsciousness or memory loss after the injury). However, most TBI's that occur each year are mild and are commonly called concussions. Unfortunately, TBI terminology does not adequately describe the injury or impairment, its treatment, or the resulting outcomes. Due to the complexity of the human brain, each person's physiology can result in different patterns of impairment and secondary conditions, requiring different treatment or rehabilitation. The intent of EPIC ClearView™ TBI Feasibility (EPIC-011) is to collect data to further develop the ClearView™ Response Scale to measure electrophysiology associated with TBI
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ClearView Scanning |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-05-01
- First posted
- 2015-06-15
- Last updated
- 2015-11-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02471625. Inclusion in this directory is not an endorsement.